Artificial T-cell receptors also known as Chimeric antigen receptor (CARs) are engineered receptor, which graft an arbitary specificity onto an immune effector cell. Artificial T cell receptors are under investigation as a therapy for cancer, using a technique called asoptive cell transfer. T cell are removed from a patient and modified so that they express receptors specific to the particular form of cancer. The T cells, which can then recognise and kill the cancer cells, are reintriduced into the patient. phase1 clinical studies of this appraoch have shown efficacy.
The top open access journals are peer reviewed scholarly journals of Genetic Engineering. The top open access journals are freely available on the public internet domain, allowing any end users to read, download, copy, distribute, prink, search or link to the full texts of the articles. These provide high quality, meticulously reviewed and rapid publication, to cater the insistent need of scientific community. These journals are indexed with all their citations noted. The top open access journals are indexed in MEDLINE, PUBMED, SCOPUS, COPERNICUS, CAS, EBSCO and ISI.
Last date updated on July, 2014